Is Dr. Agarwal's Health Care the Best Stock in Its Sector? A Look at the Numbers

Dr. Agarwal's Health Care CMP Rs 502 (25 Sep 2026). Market cap Rs 15,908 Cr. ROE 6.58%. P/E 85.92x versus Industry P/E 69.35x.

Updated: 25 Sept 2026 • 8:59 am

Posted by:

Is Dr. Agarwal's Health Care the Best Stock in Its Sector? A Look at the Numbers

Quick Answer

Dr. Agarwal's Health Care is one of the names investors compare when screening the Healthcare sector, built on a 6.58% return on equity and a P/E of 85.92x against an Industry P/E of 69.35x. Whether Dr. Agarwal's Health Care is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.

Is Dr. Agarwal's Health Care the best stock in its sector? The stock trades on the NSE at Rs 502 as of 25 September 2026, within its 52-week range of Rs 401.00 to Rs 568.00. Dr. Agarwal's Health Care Ltd operates a chain of eye care hospitals and clinics across India.

Dr. Agarwal's Health Care sits in the Healthcare sector, and its 6.58% ROE and 85.92x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector's Industry P/E benchmark.

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers

Click Here – Get Free Investment Predictions

Table of Contents

About Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Ltd operates a chain of eye care hospitals and clinics across India. It operates a chain of eye care hospitals and clinics across India, one of the country's largest eye care healthcare providers. At a market capitalisation of Rs 15,908 Cr, it is tracked as part of the Healthcare sector on Univest.

Is Dr. Agarwal's Health Care the Best Stock in Its Sector?

Dr. Agarwal's Health Care makes its case as the best stock in its sector primarily on valuation relative to its Industry P/E, combining a 6.58% ROE with a 85.92x P/E against the sector's 69.35x Industry P/E. Dr. Agarwal's Health Care's 85.92x P/E is close to the 69.35x Industry P/E, a premium built on its scale as one of India's largest eye care chains, though its 6.58% ROE is modest relative to the multiple.

Metric	Dr. Agarwal's Health Care
CMP (NSE)	Rs 502.10
52-Week High / Low	Rs 568.00 / Rs 401.00
Market Cap	Rs 15,908 Cr
P/E (TTM) vs Industry P/E	85.92x vs 69.35x
P/B	7.86
ROE	6.58%
EPS (TTM)	Rs 5.84
Dividend Yield	0.00%
Debt to Equity	0.53

Compare Dr. Agarwal's Health Care Against Other Healthcare Sector Stocks

How Dr. Agarwal's Health Care Compares Against Its Healthcare Sector Peers

The table below sets Dr. Agarwal's Health Care against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.

Company	Market Cap (Rs Cr)	P/E	ROE	Debt to Equity
Dr. Agarwal's Health Care	15,908	85.92	6.58%	0.53
Artemis Medicare Services	5,403	47.40	11.09%	0.28
CORONA Remedies	13,237	66.51	24.79%	0.22
Peer average (2 companies)	-	56.95	17.94%	0.25

Against this peer set, Dr. Agarwal's Health Care's 6.58% ROE is below the 17.94% peer average, and its P/E of 85.92x runs above the peer average of 56.95x. Dr. Agarwal's Health Care's 85.92x P/E is close to the 69.35x Industry P/E, a premium built on its scale as one of India's largest eye care chains, though its 6.58% ROE is modest relative to the multiple.

What Makes Dr. Agarwal's Health Care Worth Watching in Healthcare

Scale in eye care healthcare: Operating one of India's largest eye care hospital chains gives Dr. Agarwal's Health Care a leading position in a specialised healthcare vertical.
Moderate leverage: A debt to equity ratio of 0.53 is manageable for a hospital chain funding facility expansion.
Close to Industry P/E: An 85.92x P/E versus a 69.35x Industry P/E shows the stock trading close to Healthcare sector norms for a scaled hospital chain.

Dr. Agarwal's Health Care Valuation: Is It Justified?

Dr. Agarwal's Health Care's 85.92x P/E is close to the 69.35x Industry P/E, a premium built on its scale as one of India's largest eye care chains, though its 6.58% ROE is modest relative to the multiple. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.

Also read – Is Dhanuka Agritech the Best Stock in Its Sector? A Look at the Numbers

Download the Univest iOS App or Univest Android App to track Dr. Agarwal's Health Care and other Healthcare sector stocks.

How to Track Dr. Agarwal's Health Care Before You Invest

Before deciding whether Dr. Agarwal's Health Care deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.

Open the Univest Screener and search for Dr. Agarwal's Health Care to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.

Conclusion

Dr. Agarwal's Health Care earns a place in the best stock in its sector conversation on the strength of a 6.58% ROE and a P/E of 85.92x against a 69.35x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Is Dr. Agarwal's Health Care the best stock in its sector?

Ans. Dr. Agarwal's Health Care has a 6.58% ROE and trades at 85.92x P/E against a 69.35x Industry P/E, and compares below the peer average ROE of 17.94% in this article's named comparison, so the answer depends on what an investor is prioritising.

What is the current share price of Dr. Agarwal's Health Care?

Ans. Dr. Agarwal's Health Care was trading at Rs 502.10 on the NSE as of 25 September 2026, within its 52-week range of Rs 401.00 to Rs 568.00.

What sector does Dr. Agarwal's Health Care belong to?

Ans. Dr. Agarwal's Health Care is classified under the Healthcare sector on Univest.

How does Dr. Agarwal's Health Care compare to its sector peers on P/E?

Ans. Dr. Agarwal's Health Care's P/E of 85.92x is above the 56.95x average of the 2 named peers compared in this article.

What is Dr. Agarwal's Health Care's return on equity?

Ans. Dr. Agarwal's Health Care reported a return on equity of 6.58%, which is below the 17.94% average of its named peers in this comparison.

Should I invest in Dr. Agarwal's Health Care based on its sector position?

Ans. Dr. Agarwal's Health Care's sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.